Croda International (LON: CRDA) saw its shares increase by 1.7% today after releasing its first-quarter 2026 sales figures, which aligned with market expectations. The company reported group sales of £431 million, a 1% increase at constant currency compared to a strong Q1 2025.
The positive market reaction reflects confidence in Croda’s ability to navigate challenging market conditions. Growth in Beauty Actives and Fragrances & Flavours (F&F) sectors offset lower sales in Crop Protection, demonstrating the strength of Croda’s diversified portfolio.
Headline Numbers:
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
- Revenue: £431 million, up 1% at constant currency, matching expectations.
- Segment Performance: Consumer Care up 4%, Life Sciences down 3%, Industrial Specialties down 2% at constant currency.
Sales growth was strongest in Latin America, driven by agriculture and Consumer Care demand. North America experienced a decline due to normalization in Crop Protection demand and consumer pressures. EMEA and Asia performed as anticipated.
The Consumer Care segment saw a 4% increase, fueled by a 12% surge in Beauty Actives and a 10% rise in F&F. Beauty Actives benefited from renewed customer interest in innovation and sustained spending by higher-income households. Home Care also contributed with growth across all regions.
Life Sciences experienced a 3% decline, primarily due to an 8% drop in Crop Protection sales. Seed Enhancement showed positive growth of 2%, driven by its service-oriented business model. Pharma sales were slightly down by 2%.
Industrial Specialties reported a 2% decrease against a strong prior-year comparison, showing the impact of broader industrial trends on the sector.
The company reaffirmed its full-year 2026 outlook, despite ongoing uncertainty related to the Middle East conflict, which accounts for approximately 5% of Group sales, predominantly in F&F.
Croda’s transformation program remains on track, with a significant portion of future margin improvement under the company’s control, independent of market recovery. This initiative is expected to drive more consistent sales growth, enhanced profitability, growing cashflows, and improved returns on capital through 2028.
Driver Breakdown:
- Beauty Actives & F&F: Continued strong performance driven by innovation and consumer spending.
- Regional Strength: Latin America’s robust growth offsets challenges in North America.
- Transformation Program: On track, promising future margin improvements.
AskTraders Takeaway: The alignment with expectations and reaffirmation of the full-year outlook provide stability, potentially reducing short-term volatility. The increasing share price reflects market approval.
The company estimates the average annual currency translation impact on adjusted operating profit to be £1 million per Dollar cent movement per annum and £1 million per Euro cent movement per annum. If foreign exchange rates remain at March 2026 levels, a negative impact of approximately £4 million on reported FY26 operating profit is anticipated.
Searching for the Perfect Broker?
Discover our top-recommended brokers for trading or investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!
- IG Top-tier regulation – Read our Review
- eToro Wide range of instruments available to trade – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
